Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

December 20, 2022

Study Completion Date

December 31, 2022

Conditions
Decision Making ,SharedDe-escalation
Interventions
OTHER

Qualitative Interview or Focus group discussions

"The purpose of this study is to identify factors that influence decision-making in treatment selection and the optimal approach for sharing information about prognosis and guideline-based care.~Secondly, to further understand patient perspective on the concept of de-escalation, in which patients reduce the amount of chemotherapy to avoid side effects and (2) consider how prognosis would impact their decision-making about reducing chemotherapy (as standard or care or within a clinical trial)."

Trial Locations (1)

35249

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT03248258 - Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study) | Biotech Hunter | Biotech Hunter